Dow Today: Boeing (BA) Leads The Day Higher, Johnson & Johnson (JNJ) Lags

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

The Dow Jones Industrial Average ( ^DJI) closed up 76 points (+0.5%) at 15,376. During the day, 365.5 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 519.9 million. The NYSE advances/declines ratio closed at 1,838 issues advancing vs. 1,132 declining with 124 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

The Dow component that led the way higher today was Boeing (NYSE: BA), which sported a $1.53 gain (+1.4%) bringing the stock to $111.33. This single gain lifted the Dow Jones Industrial Average by 11.58 points or roughly accounting for 15.2% of the Dow's overall gain. Volume for Boeing ended the day at 3.5 million shares traded vs. an average daily trading volume of 5.1 million shares.

Boeing has a market cap of $82.41 billion and is part of the industrial goods sector and aerospace/defense industry. Shares are up 44.9% year to date as of Thursday's close. The stock's dividend yield sits at 1.8%.

The Boeing Company, together with its subsidiaries, engages in the design, development, manufacture, sale, and support of commercial jetliners, military aircraft, satellites, missile defense, human space flight, and launch systems and services worldwide.

TheStreet Ratings rates Boeing as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, solid stock price performance, growth in earnings per share and increase in net income. We feel these strengths outweigh the fact that the company shows low profit margins.

Holding the Dow back today was Johnson & Johnson (NYSE: JNJ), which lagged the broader Dow index with a 44-cent decline (-0.5%) bringing the stock to $88.57. Volume for Johnson & Johnson ended the day at 7.7 million shares traded vs. an average daily trading volume of 9.5 million shares.

Johnson & Johnson has a market cap of $251.46 billion and is part of the health care sector and drugs industry. Shares are up 27.3% year to date as of Thursday's close. The stock's dividend yield sits at 3%.

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics.

TheStreet Ratings rates Johnson & Johnson as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
null

If you liked this article you might like

FedEx Makes A Comeback: Cramer's Top Takeaways

Watch Out For the Dominoes That Fall: Cramer's 'Mad Money' Recap (Wed 9/20/17)

Crazy Weak U.S. Dollar Will Make These 10 Companies Huge Winners

Boeing Surge Means it's Time to Lock in More Gains